Streptavidin-Saporin: Converting Biotinylated Materials into Targeted Toxins

被引:3
作者
Ancheta, Leonardo R. [1 ]
Shramm, Patrick A. [1 ]
Bouajram, Raschel [1 ]
Higgins, Denise [1 ]
Lappi, Douglas A. [1 ]
机构
[1] Adv Targeting Syst Inc, Carlsbad, CA 92011 USA
关键词
saporin; immunotoxins; Streptavidin-ZAP; biotinylation; molecular surgery; immunolesioning; secondary conjugate; engraftment; cancer research; animal models; behavioral studies; targeted toxin; STEM-CELL TRANSPLANTATION; CLASS-I TETRAMERS; PHOTOCHEMICAL INTERNALIZATION PCI; RIBOSOME-INACTIVATING PROTEIN; TRIPLE-NEGATIVE BREAST; CD8(+) T-CELLS; SELECTIVE IMMUNOLESIONS; SAPONARIA-OFFICINALIS; CHOLINERGIC NEURONS; MEMBRANE ANTIGEN;
D O I
10.3390/toxins15030181
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Streptavidin-Saporin can be considered a type of 'secondary' targeted toxin. The scientific community has taken advantage of this conjugate in clever and fruitful ways using many kinds of biotinylated targeting agents to send saporin into a cell selected for elimination. Saporin is a ribosome-inactivating protein that causes inhibition of protein synthesis and cell death when delivered inside a cell. Streptavidin-Saporin, mixed with biotinylated molecules to cell surface markers, results in powerful conjugates that are used both in vitro and in vivo for behavior and disease research. Streptavidin-Saporin harnesses the 'Molecular Surgery' capability of saporin, creating a modular arsenal of targeted toxins used in applications ranging from the screening of potential therapeutics to behavioral studies and animal models. The reagent has become a well-published and validated resource in academia and industry. The ease of use and diverse functionality of Streptavidin-Saporin continues to have a significant impact on the life science industry.
引用
收藏
页数:19
相关论文
共 125 条
  • [1] Targeting the niche: depleting haemopoietic stem cells with targeted therapy
    Abadir, Edward
    Bryant, Christian
    Larsen, Stephen
    Clark, Georgina J.
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 961 - 968
  • [2] Depleting Syndecan-4+ T Lymphocytes Using Toxin-Bearing Dendritic Cell-Associated Heparan Sulfate Proteoglycan-Dependent Integrin Ligand: A New Opportunity for Treating Activated T Cell-Driven Disease
    Akiyoshi, Hideo
    Chung, Jin-Sung
    Tomihari, Mizuki
    Cruz, Ponciano D., Jr.
    Ariizumi, Kiyoshi
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 184 (07) : 3554 - 3561
  • [3] Intraprocedural endothelial cell seeding of arterial stents via biotin/avidin targeting mitigates in-stent restenosis
    Alferiev, Ivan S.
    Hooshdaran, Bahman
    Pressly, Benjamin B.
    Zoltick, Philip W.
    Stachelek, Stanley J.
    Chorny, Michael
    Levy, Robert J.
    Fishbein, Ilia
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
    Allers, Kristina
    Huetter, Gero
    Hofmann, Joerg
    Loddenkemper, Christoph
    Rieger, Kathrin
    Thiel, Eckhard
    Schneider, Thomas
    [J]. BLOOD, 2011, 117 (10) : 2791 - 2799
  • [5] Depletion of inflammatory dendritic cells with anti-CD209 conjugated to saporin toxin
    Alonso, Michael N.
    Gregorio, Josh G.
    Davidson, Matthew G.
    Gonzalez, Joseph C.
    Engleman, Edgar G.
    [J]. IMMUNOLOGIC RESEARCH, 2014, 58 (2-3) : 374 - 377
  • [6] Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences-Tools from the Plant Kingdom
    Ancheta, Leonardo R.
    Shramm, Patrick A.
    Bouajram, Raschel
    Higgins, Denise
    Lappi, Douglas A.
    [J]. TOXINS, 2022, 14 (03)
  • [7] Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research
    Berhani, Orit
    Glasner, Ariella
    Kahlon, Shira
    Duev-Cohen, Alexandra
    Yamin, Rachel
    Horwitz, Elad
    Enk, Jonatan
    Moshel, Ofra
    Varvak, Alexandar
    Porgador, Angel
    Jonjic, Stipan
    Mandelboim, Ofer
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (02) : 228 - 241
  • [8] Photochemical internalization (PCI) of HER2-targeted toxins Synergy is dependent on the treatment sequence
    Berstad, Maria Brandal
    Weyergang, Anette
    Berg, Kristian
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (12): : 1849 - 1858
  • [9] Bhatia S, 2011, EXPERT REV HEMATOL, V4, P437, DOI [10.1586/ehm.11.39, 10.1586/EHM.11.39]
  • [10] A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha
    Blasius, A
    Vermi, W
    Krug, A
    Facchetti, F
    Cella, M
    Colonna, M
    [J]. BLOOD, 2004, 103 (11) : 4201 - 4206